Your browser doesn't support javascript.
loading
Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer.
Yoshida, Takahiro; Jin, Kideok; Song, Hong; Park, Sunju; Huso, David L; Zhang, Zhe; Liangfeng, Han; Zhu, Charles; Bruchertseifer, Frank; Morgenstern, Alfred; Sgouros, George; Sukumar, Saraswati.
Affiliation
  • Yoshida T; Department of Oncology, Johns Hopkins University School of Medicine, Maryland, USA.
  • Jin K; Department of Oncology, Johns Hopkins University School of Medicine, Maryland, USA.
  • Song H; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Maryland, USA.
  • Park S; Department of Oncology, Johns Hopkins University School of Medicine, Maryland, USA.
  • Huso DL; Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Maryland, USA.
  • Zhang Z; Department of Oncology, Johns Hopkins University School of Medicine, Maryland, USA.
  • Liangfeng H; Department of Oncology, Johns Hopkins University School of Medicine, Maryland, USA.
  • Zhu C; Department of Biomedical Engineering, Rutgers University, Piscataway, NJ, USA.
  • Bruchertseifer F; European Commission, Joint Research Centre, Institute for Transuranium Elements, Karlsruhe, Germany.
  • Morgenstern A; European Commission, Joint Research Centre, Institute for Transuranium Elements, Karlsruhe, Germany.
  • Sgouros G; Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Maryland, USA.
  • Sukumar S; Department of Oncology, Johns Hopkins University School of Medicine, Maryland, USA.
Oncotarget ; 7(22): 33306-15, 2016 May 31.
Article in En | MEDLINE | ID: mdl-27119227
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radioisotopes / Breast Neoplasms / Actinium / Radioimmunotherapy / Carcinoma, Intraductal, Noninfiltrating / Receptor, ErbB-2 / Immunoconjugates / Radiopharmaceuticals / Alpha Particles / Trastuzumab Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Oncotarget Year: 2016 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radioisotopes / Breast Neoplasms / Actinium / Radioimmunotherapy / Carcinoma, Intraductal, Noninfiltrating / Receptor, ErbB-2 / Immunoconjugates / Radiopharmaceuticals / Alpha Particles / Trastuzumab Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Oncotarget Year: 2016 Document type: Article Affiliation country: United States Country of publication: United States